LUNAR-2: TTFields With Pembrolizumab + Platinum-based Chemotherapy for Metastatic NSCLC
Trial details
- Registry ID
- NCT06216301
- Phase
- Phase 3
Drug identity has not yet been verified against registry records
| No regulatory events match this view.This does not mean no FDA events have occurred. |